Pharmaceutical Cannabinoids: In Pursuit of Novel Scientific Research

Presented by

Purpose Investments & Zynerba Pharmaceuticals

About this talk

Medical cannabis patient counts are increasing exponentially, but what is the science behind precise formulations? What to expect Hear from Purpose Investments and Zynerba Pharmaceuticals (NASDAQ: ZYNE) – a leader in pharmaceutical cannabinoid research. • Zynerba company profile – The future of precision CBD • Pharmaceutical cannabinoids: how they differ from broad spectrum cannabinoid formulations • FDA Path: the traditional pharmaceutical approach to safe and effective medication • How to get exposure to pharmaceutical cannabinoids For professional investors only. When you trade ETFs, your capital is at risk.
Related topics:

More from this channel

Upcoming talks (4)
On-demand talks (145)
Subscribers (7189)
HANetf is an independent ETF provider founded by two of Europe’s leading ETF pioneers, Hector McNeil and Nik Bienkowski, to challenge conventional approaches to ETF product development and create distinctive opportunities for investors. HANetf’s unique UCITS ETF range is the result of close collaboration with leading asset managers that leveraged HANetf’s full-service white-label ETF platform to simplify the set-up, launch and distribution of their investment ideas.